Sung Jin Cho Selected Research

GSK5182

12/2019	Estrogen-related receptor γ controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver.
1/2018	Inverse agonist of ERRγ reduces cannabinoid receptor type 1-mediated induction of fibrinogen synthesis in mice with a high-fat diet-intoxicated liver.
1/2017	Visualization of Macrophage Recruitment to Inflammation Lesions using Highly Sensitive and Stable Radionuclide-Embedded Gold Nanoparticles as a Nuclear Bio-Imaging Platform.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sung Jin Cho Research Topics

Disease

22	Neoplasms (Cancer) 10/2021 - 11/2003
11	Stomach Neoplasms (Stomach Cancer) 09/2016 - 01/2003
8	Carcinoma (Carcinomatosis) 02/2013 - 01/2003
5	Anaplastic Thyroid Carcinoma 01/2021 - 11/2015
3	Inflammation (Inflammations) 12/2019 - 09/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2017
3	Neoplasm Metastasis (Metastasis) 10/2015 - 02/2013
2	Obesity 05/2021 - 01/2018
2	Thyroid Neoplasms (Thyroid Cancer) 11/2020 - 11/2015
2	Fatty Liver 12/2019 - 01/2018
2	Hypoxia (Hypoxemia) 09/2016 - 01/2011
2	Brain Edema (Cerebral Edema) 07/2015 - 08/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Chronic Pancreatitis 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Metabolic Diseases (Metabolic Disease) 05/2021
1	Diabetes Mellitus 05/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Alcoholic Fatty Liver 12/2019
1	Cysts 10/2019
1	Gliosis 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Neuromyelitis Optica (Devic's Disease) 02/2016
1	Autoimmune Diseases (Autoimmune Disease) 02/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2003
7	Biological ProductsIBA 04/2018 - 01/2003
6	Estrogens (Estrogen)FDA Link 11/2020 - 11/2015
4	sodium-iodide symporter (sodium iodide symporter)IBA 01/2019 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 10/2015 - 08/2007
3	EnzymesIBA 01/2022 - 11/2003
3	Orphan Nuclear ReceptorsIBA 05/2021 - 01/2019
3	GSK5182IBA 12/2019 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2017 - 11/2003
3	Glycogen Synthase (Synthase I)IBA 09/2016 - 08/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2016 - 01/2008
3	NF-kappa B (NF-kB)IBA 08/2010 - 04/2005
3	Superoxide DismutaseIBA 06/2008 - 01/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2003
2	GoldIBA 04/2018 - 01/2017
2	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2017
2	AntibodiesIBA 02/2016 - 01/2016
2	Cyclin D1IBA 01/2011 - 01/2008
1	NucleotidesIBA 01/2022
1	MethyltransferasesIBA 10/2021
1	Lysine (L-Lysine)FDA Link 10/2021
1	tryptophyltryptophanIBA 10/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2021
1	Proline (L-Proline)FDA Link 10/2021
1	tazemetostatIBA 10/2021
1	Histones (Histone)IBA 10/2021
1	TunicamycinIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 11/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2019
1	Sterol Regulatory Element Binding Protein 1IBA 12/2019
1	SterolsIBA 12/2019
1	ElementsIBA 12/2019
1	IodidesIBA 01/2019
1	Monoamine Oxidase (MAO)IBA 01/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	tetramethylrhodamine (T 489)IBA 11/2018
1	Dextrans (Dextran)FDA Link 11/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2018
1	phosphatidylinositol 3,4,5-triphosphateIBA 09/2018
1	phosphatidylinositol 3,4-diphosphateIBA 09/2018
1	phosphoinositide-3,4-bisphosphateIBA 09/2018
1	phosphoinositide-3,4,5-triphosphateIBA 09/2018
1	CrizotinibIBA 09/2018
1	Amyloid (Amyloid Fibrils)IBA 09/2018
1	Inositol (Myoinositol)IBA 09/2018
1	LipidsIBA 09/2018
1	benzimidazoleIBA 01/2017
1	Firefly LuciferasesIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	Radioisotopes (Radionuclides)IBA 01/2017
1	CarrageenanIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Messenger RNA (mRNA)IBA 09/2016
1	SulfonesIBA 02/2016
1	Immunoglobulin G (IgG)IBA 02/2016
1	Aquaporins (Water Channels)IBA 02/2016

Therapy/Procedure

9	Therapeutics 10/2021 - 10/2006
1	Trephining 10/2019
1	Photothermal Therapy 05/2019
1	Lasers (Laser) 05/2019
1	Precision Medicine 05/2019
1	Immunotherapy 01/2018
1	Chemoradiotherapy 01/2017